DiaMonTech AG
About:
DiaMonTech is developing a medical device for non-invasive measurement of blood sugar values.
Website: http://www.diamontech.de
Top Investors: IBB Ventures, Samsung Ventures, Macnica, Unorthodox Ventures, MedTech Innovator
Description:
DiaMonTech is developing a medical device for non-invasive measurement of blood sugar values. The patented process uses laser technology to determine and control blood glucose values of diabetes patients without any pain and without drawing blood.
Total Funding Amount:
$20.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Berlin, Berlin, Germany
Founded Date:
2015-01-01
Founders:
Thorsten Lubinski
Number of Employees:
11-50
Last Funding Date:
2024-05-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai